Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis

被引:0
|
作者
Jong Hwan Choi
Woo Jin Chung
Si Hyun Bae
Do Seon Song
Myeong Jun Song
Young Seok Kim
Hyung Joon Yim
Young Kul Jung
Sang Jun Suh
Jun Yong Park
Do Young Kim
Seung Up Kim
Sung Bum Cho
机构
[1] Keimyung University School of Medicine,Department of Internal Medicine
[2] The Catholic University of Korea,Department of Internal Medicine, College of Medicine
[3] Soonchunhyang University Bucheon Hospital,Department of Internal Medicine
[4] Korea University Ansan Hospital,Department of Internal Medicine
[5] Yonsei University College of Medicine,Department of Internal Medicine
[6] Chonnam National University Medical School,Department of Internal Medicine
来源
关键词
Hepatocellular carcinoma; Portal vein tumor thrombosis; Sorafenib; Hepatic arterial infusion chemotherapy; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:469 / 478
页数:9
相关论文
共 50 条
  • [41] Efficacy and safety of sorafenib plus hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma
    Regmi, Parbatraj
    Hu, Hai-Jie
    Lv, Tian-Run
    Paudyal, Aliza
    Sah, Ram Babu
    Ma, Wen-Jie
    Jin, Yan-Wen
    Li, Fu-Yu
    SURGICAL ONCOLOGY-OXFORD, 2021, 39
  • [42] Sorafenib vs. Lenvatinib as First-line Therapy for Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis
    Kuzuya, Teiji
    Ishigami, Masatoshi
    Ito, Takanori
    Ishizu, Yoji
    Honda, Takashi
    Ishikawa, Tetsuya
    Fujishiro, Mitsuhiro
    ANTICANCER RESEARCH, 2020, 40 (04) : 2283 - 2290
  • [43] Hepatic Arterial Infusion Chemotherapy Combined with Radiation Therapy for Advanced Hepatocellular Carcinoma with Tumor Thrombosis of the Main Trunk or Bilobar of the Portal Vein
    Kosaka, Yumi
    Kimura, Tomoki
    Kawaoka, Tomokazu
    Ogawa, Yutaro
    Amioka, Kei
    Naruto, Kensuke
    Yoshikawa, Yuki
    Kikukawa, Chihiro
    Suehiro, Yosuke
    Yamaoka, Kenji
    Ando, Yuwa
    Uchikawa, Shinsuke
    Morio, Kei
    Nakahara, Takashi
    Murakami, Eisuke
    Takahashi, Shoichi
    Tsuge, Masataka
    Hiramatsu, Akira
    Imamura, Michio
    Chosa, Keigo
    Awai, Kazuo
    Nagata, Yasushi
    Chayama, Kazuaki
    Aikata, Hiroshi
    LIVER CANCER, 2021, 10 (02) : 151 - 160
  • [44] Phase II Study of Concurrent Sorafenib and Radiotherapy for Advanced Hepatocellular Carcinoma With Portal Vein and/or Hepatic Vein Tumor Thrombosis
    Chen, B.
    Li, Y. X.
    Wang, L.
    Wu, J.
    Zhai, Y. R.
    Wu, F.
    Zeng, H.
    Rong, W.
    Wang, S. L.
    Wang, J.
    Yang, Z.
    Yu, T.
    Tang, Y.
    Li, N.
    Fang, H.
    Liu, Y. P.
    Song, Y. W.
    Lu, N. N.
    Jing, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S39 - S39
  • [45] Hepatic Arterial Infusion Therapy with a Fine Powder Formulation of Cisplatin for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
    Kondo, Masaaki
    Morimoto, Manabu
    Numata, Kazushi
    Nozaki, Akito
    Tanaka, Katsuaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (01) : 69 - 75
  • [46] A multi-institutional phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis
    Masafumi Ikeda
    Takuji Okusaka
    Junji Furuse
    Shuichi Mitsunaga
    Hideki Ueno
    Hidekazu Yamaura
    Yoshitaka Inaba
    Yoshito Takeuchi
    Mitsuo Satake
    Yasuaki Arai
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 463 - 470
  • [47] A multi-institutional phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis
    Ikeda, Masafumi
    Okusaka, Takuji
    Furuse, Junji
    Mitsunaga, Shuichi
    Ueno, Hideki
    Yamaura, Hidekazu
    Inaba, Yoshitaka
    Takeuchi, Yoshito
    Satake, Mitsuo
    Arai, Yasuaki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (02) : 463 - 470
  • [48] Hepatic arterial infusion chemotherapy versus sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombus: An updated meta-analysis and systematic review
    Zhang, Wei
    Ouyang, Deliang
    Huang, Zhangkan
    Che, Xu
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [49] Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma
    Lyu, Ning
    Kong, Yanan
    Mu, Luwen
    Lin, Youen
    Li, Jibin
    Liu, Yaru
    Zhang, Zhenfeng
    Zheng, Lie
    Deng, Haijing
    Li, Shaolong
    Xie, Qiankun
    Guo, Rongping
    Shi, Ming
    Xu, Li
    Cai, Xiuyu
    Wu, Peihong
    Zhao, Ming
    JOURNAL OF HEPATOLOGY, 2018, 69 (01) : 60 - 69
  • [50] Phase I/II study of sorafenib in combination with intermittent hepatic arterial infusion chemotherapy using cisplatin for unresectable advanced hepatocellular carcinoma with portal vein tumor thrombus
    Ishizaki, Morihiko
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)